Viewing Study NCT07311551


Ignite Creation Date: 2026-03-26 @ 3:17 PM
Ignite Modification Date: 2026-03-31 @ 10:45 AM
Study NCT ID: NCT07311551
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-31
First Post: 2025-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI)
Sponsor: Bhavya Bhavya, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module